Poseida Therapeutics, Inc. (PSTX)
NASDAQ: PSTX · IEX Real-Time Price · USD
3.080
+0.270 (9.61%)
At close: Mar 27, 2024, 4:00 PM
3.079
-0.001 (-0.03%)
After-hours: Mar 27, 2024, 7:00 PM EDT
Poseida Therapeutics Market Cap
Poseida Therapeutics has a market cap or net worth of $297.19 million as of March 28, 2024. Its market cap has decreased by -11.71% in one year.
Market Cap
297.19M
Enterprise Value
170.41M
1-Year Change
-11.71%
Ranking
Category
Stock Price
$3.08
Market Cap Chart
Since July 10, 2020, Poseida Therapeutics's market cap has decreased from $948.90M to $297.19M, a decrease of -68.68%. That is a compound annual growth rate of -26.86%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 26, 2024 | 271.10M | -7.57% |
Mar 25, 2024 | 293.30M | -2.27% |
Mar 22, 2024 | 300.10M | 2.32% |
Mar 21, 2024 | 293.30M | 2.34% |
Mar 20, 2024 | 286.60M | 2.07% |
Mar 19, 2024 | 280.80M | -4.91% |
Mar 18, 2024 | 295.30M | -4.96% |
Mar 15, 2024 | 310.70M | -0.61% |
Mar 14, 2024 | 312.60M | -4.98% |
Mar 13, 2024 | 329.00M | 7.55% |
Mar 12, 2024 | 305.90M | -7.02% |
Mar 11, 2024 | 329.00M | -16.22% |
Mar 8, 2024 | 392.70M | 18.64% |
Mar 7, 2024 | 331.00M | -3.58% |
Mar 6, 2024 | 343.30M | 3.16% |
Mar 5, 2024 | 332.80M | -5.56% |
Mar 4, 2024 | 352.40M | -10.76% |
Mar 1, 2024 | 394.90M | 4.28% |
Feb 29, 2024 | 378.70M | 6.47% |
Feb 28, 2024 | 355.70M | -1.33% |
Feb 27, 2024 | 360.50M | 8.95% |
Feb 26, 2024 | 330.90M | 6.47% |
Feb 23, 2024 | 310.80M | 0.94% |
Feb 22, 2024 | 307.90M | -3.60% |
Feb 21, 2024 | 319.40M | -4.83% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Enanta Pharmaceuticals | 308.67M |
Verastem | 304.56M |
Gossamer Bio | 304.54M |
AC Immune | 303.62M |
Senseonics Holdings | 300.68M |
Immutep | 299.57M |
RAPT Therapeutics | 296.48M |
Nanobiotix | 296.14M |